Back to Agenda
Charting the Biosimilars Beat Drop: The Latest Updates in the Biosimilars Landscape, Coverage, and Adoption in the US
Session Chair(s)
Charlie Dragovich, RPh
Board of Directors
California Academy of Managed Care Pharmacy, United States
This session will provide an overview of today’s biosimilars landscape, explore trends in uptake, describe innovative programs from industry disruptors, and report perspectives from key stakeholders through their primary market research.
Learning Objective : Summarize results of current payer and provider research on barriers to biosimilar coverage and adoption, with a focus on product interchangeability; Describe the challenges and solutions of real-world data (RWD) and real-world evidence (RWE) in decision-making; Identify a framework for operational readiness in biosimilar management.
Speaker(s)
Industry Update
Chara Reid, PharmD, RPh
Cencora (formerly AmerisourceBergen), United States
Director, Specialty Practice Network, Immunology
Industry Update
Catherine Lockhart, PharmD, PhD, MS
Biologics and Biosimilars Collective Intelligence Consortium, United States
Chief Science Officer
Have an account?